Search

Author/Creator Jebbink, M.

2. Trastuzumab and pertuzumab combination therapy for advanced pre-treated HER2 exon 20-mutated non-small cell lung cancer. (August 2022)

Authors:
van Berge Henegouwen, J.M.; Jebbink, M.; Hoes, L.R.; van der Wijngaart, H.; Zeverijn, L.J.; van der Velden, D.L.; Roepman, P.; de Leng, W.W.J.; Jansen, A.M.L.; van Werkhoven, E.; van der Noort, V.; van der Wekken, A.J.; de Langen, A.J.; Voest, E.E.; Verheul, H.M.W.; Smit, E.F.; Gelderblom, H.
Journal:
European journal of cancer
Issue:
Volume 171(2022)
Page Start:
114
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search